{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T11:44:53Z","timestamp":1771328693130,"version":"3.50.1"},"reference-count":15,"publisher":"BMJ","license":[{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Neurol Neurosurg Psychiatry"],"accepted":{"date-parts":[[2025,9,24]]},"abstract":"<jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Late-onset Pompe disease has a characteristic pattern of fat replacement and wasting of especially axial and hamstring muscles. This characteristic pattern of muscle degeneration is still to be explained but could relate to differences in how glycogen is deposited in the different muscles. This cross-sectional observational study investigates the glycogen levels of different muscle groups in young late-onset Pompe subjects and matched controls.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>\n                     <jats:sup>13<\/jats:sup>C-MR Spectroscopy at 7 Tesla field strength was used to quantify glycogen concentration in four muscle groups: the calf, hamstring, anterior thigh and lumbar muscles of patients with late-onset Pompe disease and healthy controls. An unpaired t-test with correction for multiple comparisons was used to test the difference between Pompe subjects and healthy controls for each muscle area.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>11 late-onset Pompe patients (6 female, mean age 31, range 20\u201344) and 16 healthy volunteers (10 female, mean age 27, range 19\u201335) were included. We found that Pompe subjects had 1.8 (95% CI 1.56 to 2.16) times more glycogen in hamstring muscles (p\u22640.001) and 2.2 (95% CI 1.24 to 2.48) times more in lumbar muscles (p\u22640.004), 1.4 (95% CI 1.07 to 1.73) times more in the anterior thigh muscles (p=0.045) while levels were similar to healthy persons in the calf (95%\u2009CI 0.83 to 1.12, p=0.7).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>The first muscles to degenerate in Pompe disease are hamstring and paraspinals. Our findings, therefore, suggest that high glycogen levels precede fatty degeneration of muscles, and that monitoring glycogen levels could be an important biomarker to assess treatment effect in Pompe disease.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/jnnp-2025-336628","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T17:21:18Z","timestamp":1760548878000},"page":"jnnp-2025-336628","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Quantification of muscle glycogen distribution in Pompe disease using 7 Tesla <sup>13<\/sup>C NMR spectroscopy"],"prefix":"10.1136","author":[{"given":"Gry H","family":"Beha","sequence":"first","affiliation":[{"name":"Copenhagen Neuromuscular Center, Department of Neurology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4566-4156","authenticated-orcid":false,"given":"Mads Godtfeldt","family":"Stemmerik","sequence":"additional","affiliation":[{"name":"Copenhagen Neuromuscular Center, Department of Neurology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent O","family":"Boer","sequence":"additional","affiliation":[{"name":"Danish Research Centre for Magnetic Resonance, Centre for Functional and Diagnostic Imaging and Research, Copenhagen University Hospital, Copenhagen, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ans T","family":"van der Ploeg","sequence":"additional","affiliation":[{"name":"Center for Lysosomal and Metabolic Diseases, Erasmus MC University Medical Center Rotterdam, Rotterdam, Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadine AME","family":"van der Beek","sequence":"additional","affiliation":[{"name":"Center for Lysosomal and Metabolic Diseases, Erasmus MC University Medical Center Rotterdam, Rotterdam, Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henning","family":"Andersen","sequence":"additional","affiliation":[{"name":"Department of Neurology, Aarhus Universitetshospital, Aarhus, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anouk","family":"Marsman","sequence":"additional","affiliation":[{"name":"Danish Research Centre for Magnetic Resonance, Centre for Functional and Diagnostic Imaging and Research, Copenhagen University Hospital, Copenhagen, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura N","family":"Jacobsen","sequence":"additional","affiliation":[{"name":"Copenhagen Neuromuscular Center, Department of Neurology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maudy T M","family":"Theunissen","sequence":"additional","affiliation":[{"name":"Center for Lysosomal and Metabolic Diseases, Erasmus MC University Medical Center Rotterdam, Rotterdam, Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esben T","family":"Petersen","sequence":"additional","affiliation":[{"name":"Danish Research Centre for Magnetic Resonance, Centre for Functional and Diagnostic Imaging and Research, Copenhagen University Hospital, Copenhagen, Denmark"},{"name":"Center for Magnetic Resonance, Department of Health Technology, Technical University of Denmark, Lyngby, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Vissing","sequence":"additional","affiliation":[{"name":"Copenhagen Neuromuscular Center, Department of Neurology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2025,10,15]]},"reference":[{"key":"2025101510202376000_jnnp-2025-336628v1.1","first-page":"506","article-title":"Late-onset Pompe\u2019s disease","volume":"32","author":"Teener","year":"2012","journal-title":"Semin Neurol"},{"key":"2025101510202376000_jnnp-2025-336628v1.2","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/mus.27099","article-title":"Skeletal muscle magnetic resonance imaging in Pompe disease","volume":"63","author":"D\u00edaz-Manera","year":"2021","journal-title":"Muscle Nerve"},{"key":"2025101510202376000_jnnp-2025-336628v1.3","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-29170-7"},{"key":"2025101510202376000_jnnp-2025-336628v1.4","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1002\/jcsm.12555","article-title":"Follow-up of late-onset Pompe disease patients with muscle magnetic resonance imaging reveals increase in fat replacement in skeletal muscles","volume":"11","author":"Nu\u00f1ez-Peralta","year":"2020","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2025101510202376000_jnnp-2025-336628v1.5","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s10545-015-9825-9","article-title":"Skeletal muscle quantitative nuclear magnetic resonance imaging follow-up of adult Pompe patients","volume":"38","author":"Carlier","year":"2015","journal-title":"J Inherit Metab Dis"},{"key":"2025101510202376000_jnnp-2025-336628v1.6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0108706","article-title":"Reproducibility and absolute quantification of muscle glycogen in patients with glycogen storage disease by 13C NMR spectroscopy at 7 Tesla","volume":"9","author":"Heinicke","year":"2014","journal-title":"PLoS One"},{"key":"2025101510202376000_jnnp-2025-336628v1.7","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-015-0412-3"},{"key":"2025101510202376000_jnnp-2025-336628v1.8","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/ajmg.c.31317","article-title":"Autophagy and mitochondria in Pompe disease: nothing is so new as what has long been forgotten","volume":"160C","author":"Raben","year":"2012","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"2025101510202376000_jnnp-2025-336628v1.9","first-page":"S42","article-title":"Autophagy in skeletal muscle: implications for Pompe disease","volume":"47 Suppl 1","author":"Shea","year":"2009","journal-title":"Int J Clin Pharmacol Ther"},{"key":"2025101510202376000_jnnp-2025-336628v1.10","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0960-8966(03)00069-5","article-title":"Evaluation of muscle glycogen content by 13C NMR spectroscopy in adult-onset acid maltase deficiency","volume":"13","author":"Wary","year":"2003","journal-title":"Neuromuscul Disord"},{"key":"2025101510202376000_jnnp-2025-336628v1.11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0909859"},{"key":"2025101510202376000_jnnp-2025-336628v1.12","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/S1474-4422(21)00331-8","article-title":"Safety and efficacy of cipaglucosidase alfa plus miglustat versus alglucosidase alfa plus placebo in late-onset Pompe disease (PROPEL): an international, randomised, double-blind, parallel-group, phase 3 trial","volume":"20","author":"Schoser","year":"2021","journal-title":"Lancet Neurol"},{"key":"2025101510202376000_jnnp-2025-336628v1.13","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(21)00241-6"},{"key":"2025101510202376000_jnnp-2025-336628v1.14","doi-asserted-by":"crossref","first-page":"e536","DOI":"10.1212\/WNL.0000000000200746","article-title":"Long-term Safety and Efficacy of Avalglucosidase Alfa in Patients With Late-Onset Pompe Disease","volume":"99","author":"Dimachkie","year":"2022","journal-title":"Neurology"},{"key":"2025101510202376000_jnnp-2025-336628v1.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2016.05.013"}],"container-title":["Journal of Neurology, Neurosurgery &amp; Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jnnp-2025-336628","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T17:21:20Z","timestamp":1760548880000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnnp.bmj.com\/lookup\/doi\/10.1136\/jnnp-2025-336628"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,15]]},"references-count":15,"alternative-id":["10.1136\/jnnp-2025-336628"],"URL":"https:\/\/doi.org\/10.1136\/jnnp-2025-336628","relation":{},"ISSN":["0022-3050","1468-330X"],"issn-type":[{"value":"0022-3050","type":"print"},{"value":"1468-330X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,15]]}}}